View Older Stories

Nov 26, 2025 04:01PM Pacira BioSciences sues WhiteOak, Qilu over EXPAREL patent infringement

Nov 17, 2025 06:46AM H.C. Wainwright Assumes Pacira Pharmaceuticals (PCRX) at Buy

Nov 7, 2025 12:50AM Pacira Pharma (PCRX) Tops Q3 EPS by 5c ; Offers Guidance

Oct 27, 2025 08:04AM Pacira BioSciences faces generic challenge to EXPAREL pain drug

Oct 21, 2025 08:32AM Pacira BioSciences faces generic challenge to EXPAREL drug

Oct 20, 2025 04:03PM Pacira BioSciences to present 3-year PCRX-201 gene therapy data at conference

Oct 2, 2025 05:00PM PharmaCorp closes three pharmacy acquisitions across Canada

Aug 6, 2025 01:53AM Pacira Pharma (PCRX) Tops Q2 EPS by 2c ; Offers Guidance

Jul 25, 2025 06:02AM Truist Securities Upgrades Pacira Pharmaceuticals (PCRX) to Hold

Jul 22, 2025 09:03AM Pacira BioSciences partners with J&J MedTech to expand ZILRETTA reach

Jul 10, 2025 07:40AM Pacira BioSciences (PCRX) instituted a reduction in force

Jun 26, 2025 10:57AM PHARMACORP RX (PCRX) to acquire PharmaChoice Canada business in Western Canada for $2.4 million

May 27, 2025 03:47PM Grabar Law Office Investigates Claims on Behalf of Shareholders of Pacira Biosciences Inc. (PCRX)

May 15, 2025 08:00AM Pacira BioSciences (PCRX) Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 9, 2025 01:56AM Pacira Pharma (PCRX) Tops Q1 EPS by 3c ; Offers Guidance

Apr 21, 2025 08:16AM DOMA Perpetual Supports Pacira's (PCRX) New $300M Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders

Apr 17, 2025 05:01PM Pacira BioSciences (PCRX) Reaffirms Commitment to Enhancing Value for All Shareholders

Apr 8, 2025 10:14AM Pacira Pharmaceuticals (PCRX) PT Raised to $26 at RBC Capital

Apr 8, 2025 06:41AM Pacira Pharmaceuticals (PCRX) PT Raised to $65 at H.C. Wainwright

Apr 8, 2025 04:55AM Raymond James Reiterates Market Perform Rating on Pacira Pharmaceuticals (PCRX)

Apr 7, 2025 04:35PM After-hours movers: Broadcom, Levi, Human and more

Apr 7, 2025 04:30PM Pacira BioSciences (PCRX) Announces Settlement of U.S. Patent Litigation for EXPAREL

Apr 3, 2025 08:03AM Pacira BioSciences (PCRX) Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

Mar 14, 2025 04:06PM Pacira BioSciences (PCRX) Confirms Receipt of Director Nominations from DOMA Perpetual

Mar 14, 2025 04:00PM FINAL REMINDER PCRX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Pacira BioSciences, Inc. Investors to Participate in the Class Action Lawsuit

Mar 14, 2025 08:27AM DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences (PCRX)

Mar 13, 2025 04:00PM FINAL PCRX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Pacira BioSciences, Inc. Investors to Join the Class Action Lawsuit

Mar 12, 2025 05:16PM Faruqi & Faruqi Reminds Pacira BioSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

Mar 10, 2025 01:58PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

Mar 8, 2025 02:17PM PCRX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Secu

Mar 7, 2025 12:29PM PCRX FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities

Mar 2, 2025 11:30AM PCRX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities

Mar 1, 2025 11:05AM PCRX FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities Cl

Mar 1, 2025 09:08AM Faruqi & Faruqi Reminds Pacira BioSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

Feb 28, 2025 08:03AM Pacira Pharmaceuticals (PCRX) PT Raised to $32 at Needham

Feb 28, 2025 07:15AM Pacira Pharmaceuticals (PCRX) PT Raised to $48 at H.C. Wainwright

Feb 27, 2025 04:20PM Pacira Pharma (PCRX) Tops Q4 EPS by 12c ; Offers Guidance

Feb 27, 2025 04:00PM Pacira BioSciences (PCRX) Acquires Remaining Equity Stake of GQ Bio

Feb 27, 2025 04:00PM Pacira BioSciences (PCRX) Acquires Remaining Equity Stake of GQ Bio

Feb 25, 2025 02:02PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX

Feb 25, 2025 10:46AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

Feb 23, 2025 09:17AM ROSEN, NATIONAL TRIAL COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX

Feb 21, 2025 09:41AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

Feb 20, 2025 07:45PM ROSEN, A TOP RANKED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX

Feb 19, 2025 02:57PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX

Feb 19, 2025 06:04AM Pacira Pharmaceuticals (PCRX) PT Raised to $21 at JPMorgan

Feb 17, 2025 11:45AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

Feb 15, 2025 09:27AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

Feb 11, 2025 03:18PM Faruqi & Faruqi Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

View Older Stories